Solvay SA Website

Solvay SA

ENXTBR-SOLB

Basic

  • Market Cap

    €3,422.21M

  • EV

    €5,068.21M

  • Shares Out

    105.01M

  • Revenue

    €5,570M

  • Employees

    9,000

Margins

  • Gross

    22.32%

  • EBITDA

    23.07%

  • Operating

    12.73%

  • Pre-Tax

    5.89%

  • Net

    35.08%

  • FCF

    15.82%

Returns (5Yr Avg)

  • ROA

    3.81%

  • ROTA

    10.16%

  • ROE

    8.28%

  • ROCE

    7.09%

  • ROIC

    4.07%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €31.9

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €721M

  • Net Debt

    €1,586M

  • Debt/Equity

    1.56

  • EBIT/Interest

    8.97

Growth (CAGR)

  • Rev 3Yr

    -16.68%

  • Rev 5Yr

    -13.27%

  • Rev 10Yr

    -5.76%

  • Dil EPS 3Yr

    20.31%

  • Dil EPS 5Yr

    14.18%

  • Dil EPS 10Yr

    18.12%

  • Rev Fwd 2Yr

    -0.51%

  • EBITDA Fwd 2Yr

    -7.41%

  • EPS Fwd 2Yr

    -43.28%

  • EPS LT Growth Est

    -11.52%

Dividends

  • Yield

  • Payout

    199.9%

  • DPS

    €2.43

  • DPS Growth 3Yr

    -13.47%

  • DPS Growth 5Yr

    -8.31%

  • DPS Growth 10Yr

    -2.72%

  • DPS Growth Fwd 2Yr

    1.03%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Operating Revenues

10,244

8,965

10,105

5,539

4,880

4,691

Other Revenues, Total

983

749

1,329

2,440

1,144

879

Total Revenues

11,227

9,714

11,434

7,979

6,024

5,570

Total Revenues % Chg.

-0.6%

-13.5%

17.7%

-30.2%

-24.5%

-7.8%

Cost of Goods Sold, Total

8,244

7,207

8,508

6,554

4,642

4,327

Gross Profit

2,983

2,507

2,926

1,425

1,382

1,243

Selling General & Admin Expenses, Total

1,331

1,212

1,233

565

552

510

R&D Expenses

323

300

325

46

47

45

Other Operating Expenses

159

134

157

-310

-10

-21

Other Operating Expenses, Total

1,813

1,646

1,715

301

589

534

Operating Income

1,170

861

1,211

1,124

793

709

Interest Expense, Total

-128

-112

-99

-43

-65

-79

Interest And Investment Income

15

8

9

16

36

32

Net Interest Expenses

-113

-104

-90

-27

-29

-47

Income (Loss) On Equity Invest.

95

58

158

153

53

50

Currency Exchange Gains (Loss)

-9

-9

24

3

3

Other Non Operating Income (Expenses)

-115

-76

-5

23

-47

-37

EBT, Excl. Unusual Items

1,028

730

1,274

1,297

773

678

Restructuring Charges

-23

-122

-181

-13

-51

-62

Merger & Related Restructuring Charges

-5

-25

-47

-83

-404

-404

Impairment of Goodwill

-758

-1,050

-38

-38

Gain (Loss) On Sale Of Investments

9

-8

9

4

-3

Gain (Loss) On Sale Of Assets

11

3

12

3

3

3

Asset Writedown

-108

-351

37

-57

-57

Legal Settlements

-20

61

Other Unusual Items

-81

-1

-34

-110

-50

211

EBT, Incl. Unusual Items

73

-844

1,094

1,131

180

328

Income Tax Expense

153

248

110

228

208

192

Earnings From Continuing Operations

-80

-1,092

984

903

-28

136

Earnings Of Discontinued Operations

236

163

5

1,016

2,130

1,827

Minority Interest

-38

-33

-41

-14

-9

-9

Net Income

118

-962

948

1,905

2,093

1,954

Net Income to Common Incl Extra Items

118

-962

948

1,905

2,093

1,954

Net Income to Common Excl. Extra Items

-118

-1,125

943

889

-37

127

Total Shares Outstanding

103.4

103.2

103.6

103.8

105

105.1

Weighted Avg. Shares Outstanding

103.2

103.1

103.5

103.7

104.2

104.5

Weighted Avg. Shares Outstanding Dil

103.4

103.1

103.8

104.1

104.2

104.5

EPS

1.1

-9.3

9.2

18.4

20.1

18.7

EPS Diluted

1.1

-9.3

9.1

18.3

20.1

18.7

EBITDA

2,090

1,716

1,946

1,898

1,523

1,285

Effective Tax Rate

209.6%

-29.4%

10.1%

20.2%

115.6%

58.5%